bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2929
+0.0061 (2.13%)
At close: Jul 15, 2025, 4:00 PM
0.3005
+0.0076 (2.59%)
After-hours: Jul 15, 2025, 5:32 PM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $8.06 million as of July 15, 2025. Its market cap has decreased by -63.60% in one year.
Market Cap
8.06M
Enterprise Value
8.78M
1-Year Change
-63.60%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $8.06M, a decrease of -82.09%. That is a compound annual growth rate of -45.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 7.90M | -44.33% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.60B |
| Johnson & Johnson | 377.32B |
| AbbVie | 338.30B |
| Novo Nordisk | 308.09B |
| UnitedHealth Group | 272.67B |
| Novartis AG | 237.08B |
| Abbott Laboratories | 229.71B |
| AstraZeneca | 222.35B |